Literature DB >> 12515546

Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression.

Zheng-ping Xu1, Takanori Tsuji, James F Riordan, Guo-fu Hu.   

Abstract

Angiogenin undergoes nuclear translocation in endothelial and smooth muscle cells where it accumulates in the nucleolus and binds to DNA. Nuclear translocation of angiogenin is necessary for its biological activity and is mediated by an endocytotic pathway that is independent of the microtubule system and lysosomal processing. Because the nucleolus is a subnuclear organelle containing clusters of transcriptionally active ribosomal RNA genes, we studied the binding of angiogenin to the intergenic spacer of the ribosomal RNA gene where many of the transcription regulatory elements are located. Here we report that angiogenin binds to CT repeats that are abundant in the nontranscribed region of the ribosomal RNA gene. An angiogenin-binding DNA sequence (CTCTCTCTCTCTCTCTCCCTC) has been identified and designated angiogenin-binding element (ABE). ABE binds angiogenin specifically and exhibits angiogenin-dependent promoter activity in a luciferase reporter system. CT repeats, or inverted GA box, which are abundantly distributed in the eukaryotic genome and are often located in the 5'-flanking region, have been implicated in regulating gene expression. We have previously shown that angiogenin stimulates rRNA synthesis. The present results suggest that the nuclear function of angiogenin may not only be related to rRNA production but also play a role in regulating expression of genes containing CT repeats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12515546     DOI: 10.1021/bi020465x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  55 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.

Authors:  Nitika Paudel; Sathish Sadagopan; Sandhya Balasubramanian; Bala Chandran
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 2.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

3.  Mechanism and Function of Angiogenin in Hematopoietic Malignancy.

Authors:  Kevin A Goncalves; Guo-Fu Hu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-23

4.  A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation.

Authors:  Norie Yoshioka; Li Wang; Koji Kishimoto; Takanori Tsuji; Guo-fu Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

Review 5.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

6.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

7.  Can't you hear me knocking: contact-dependent competition and cooperation in bacteria.

Authors:  Allison M Jones; David A Low; Christopher S Hayes
Journal:  Emerg Top Life Sci       Date:  2017-04-21

8.  Neamine inhibits oral cancer progression by suppressing angiogenin-mediated angiogenesis and cancer cell proliferation.

Authors:  Koji Kishimoto; Shoko Yoshida; Soichiro Ibaragi; Norie Yoshioka; Guo-Fu Hu; Akira Sasaki
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

9.  Naturally extended CT . AG repeats increase H-DNA structures and promoter activity in the smooth muscle myosin light chain kinase gene.

Authors:  Yoo-Jeong Han; Primal de Lanerolle
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

10.  Neamine induces neuroprotection after acute ischemic stroke in type one diabetic rats.

Authors:  R Ning; M Chopp; A Zacharek; T Yan; C Zhang; C Roberts; M Lu; J Chen
Journal:  Neuroscience       Date:  2013-11-08       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.